Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis
出版年份 2013 全文链接
标题
Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 16, Issue 5, Pages 410-417
出版商
Wiley
发表日期
2013-11-10
DOI
10.1111/dom.12233
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control
- (2013) Helena Rodbard et al. Endocrine Practice
- Assessment of AACE/ACE Recommendations for Initial Dual Antihyperglycemic Therapy Using the Fixed-Dose Combination of Sitagliptin and Metformin Versus Metformin
- (2013) Samuel Engel et al. Endocrine Practice
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial
- (2012) R. R. Henry et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes
- (2011) Valerie Hutchins et al. CURRENT MEDICAL RESEARCH AND OPINION
- Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks
- (2011) A. Pfützner et al. DIABETES OBESITY & METABOLISM
- A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents
- (2011) L. Olansky et al. DIABETES OBESITY & METABOLISM
- A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 d
- (2011) J. L. C. Borges et al. DIABETES OBESITY & METABOLISM
- Initial Combination Therapy for Type 2 Diabetes Mellitus: Is It Ready for Prime Time?
- (2010) Bernard Zinman AMERICAN JOURNAL OF MEDICINE
- Effects of Rosiglitazone/Metformin Fixed-Dose Combination Therapy and Metformin Monotherapy on Serum Vaspin, Adiponectin and IL-6 Levels in Drug-Naïve Patients with Type 2 Diabetes
- (2010) N. P. E. Kadoglou et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes
- (2010) Olivia J. Phung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
- (2009) Alfonso Perez et al. CURRENT MEDICAL RESEARCH AND OPINION
- Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study
- (2009) Debora Williams-Herman et al. CURRENT MEDICAL RESEARCH AND OPINION
- Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus
- (2009) E. Bosi et al. DIABETES OBESITY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now